Acyclovir
- Product NDC
- 50090-1568
- 11-digit product format
- 500901568
- Labeler code
- 50090
- Product ID
- 50090-1568_3b1281ac-3206-4a60-bcc2-937c3936e8a0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA203834
- Marketing category
- ANDA
- Marketing start
- 2013-11-29
- Marketing end
- 0000-00-00
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50090-1568-0 | 50090156800 | 90 TABLET in 1 BOTTLE (50090-1568-0) | 90 tablet | 2014-12-22 | 0000-00-00 | No | No | Current |
| 50090-1568-1 | 50090156801 | 21 TABLET in 1 BOTTLE (50090-1568-1) | 21 tablet | 2016-04-18 | 0000-00-00 | No | No | Current |